07595566 · Active · incorporated 15 years, 3 months ago · Cambridge
Biotech AI Biotech & Life Sciences Data & Analytics Drug Discovery Series B+
Develops iPSC cell models and uses AI phenomics for drug discovery, focusing on metabolic and liver-related diseases.
See the complete cap table with every shareholder, founder tags, dilution across 22 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.